Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

The Need for Medication Reconciliation Increases with Age.

Rappaport R, Arinzon Z, Feldman J, Lotan S, Heffez-Aizenfeld R, Berner Y.

Isr Med Assoc J. 2017 Oct;19(10):625-630.

2.

Growth hormone deficiency: optimizing therapy and new issues.

Rappaport R.

Indian J Pediatr. 2012 Feb;79(2):224-8. doi: 10.1007/s12098-011-0598-3. Epub 2011 Oct 29. Review.

PMID:
22037859
3.

A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older.

Forrest BD, Steele AD, Hiemstra L, Rappaport R, Ambrose CS, Gruber WC.

Vaccine. 2011 May 9;29(20):3633-9. doi: 10.1016/j.vaccine.2011.03.029. Epub 2011 Apr 5.

PMID:
21440036
4.

Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.

Lum LC, Borja-Tabora CF, Breiman RF, Vesikari T, Sablan BP, Chay OM, Tantracheewathorn T, Schmitt HJ, Lau YL, Bowonkiratikachorn P, Tam JS, Lee BW, Tan KK, Pejcz J, Cha S, Gutierrez-Brito M, Kaltenis P, Vertruyen A, Czajka H, Bojarskas J, Brooks WA, Cheng SM, Rappaport R, Baker S, Gruber WC, Forrest BD.

Vaccine. 2010 Feb 10;28(6):1566-74. doi: 10.1016/j.vaccine.2009.11.054. Epub 2009 Dec 8.

PMID:
20003918
5.

Efficacy and safety of a live attenuated influenza vaccine in adults 60 years of age and older.

De Villiers PJ, Steele AD, Hiemstra LA, Rappaport R, Dunning AJ, Gruber WC, Forrest BD; LAIV Elderly Study Trial Network.

Vaccine. 2009 Dec 10;28(1):228-34. doi: 10.1016/j.vaccine.2009.09.092. Epub 2009 Sep 29.

PMID:
19796721
6.

A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children.

Breiman RF, Brooks WA, Goswami D, Lagos R, Borja-Tabora C, Lanata CF, Londoño JA, Lum LC, Rappaport R, Razmpour A, Walker RE, Gruber WC, Forrest BD.

Vaccine. 2009 Sep 4;27(40):5472-9. doi: 10.1016/j.vaccine.2009.07.002. Epub 2009 Jul 17.

PMID:
19616493
7.

An in vitro study of the protective effect of relaxin on brain tissue under ischemic stress.

Wilson BC, Rappaport R.

Ann N Y Acad Sci. 2009 Apr;1160:265-8. doi: 10.1111/j.1749-6632.2008.03806.x.

PMID:
19416201
8.

Treatment approaches of growth failure.

Rappaport R.

Pediatr Endocrinol Rev. 2008 Dec;6(2):257. No abstract available.

PMID:
19209477
9.

Relaxin-3 and RXFP3 expression, and steroidogenic actions in the ovary of teleost fish.

Wilson BC, Burnett D, Rappaport R, Parry LJ, Fletcher EK.

Comp Biochem Physiol A Mol Integr Physiol. 2009 May;153(1):69-74. doi: 10.1016/j.cbpa.2008.09.020. Epub 2008 Sep 26.

PMID:
18852059
10.

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.

Forrest BD, Pride MW, Dunning AJ, Capeding MR, Chotpitayasunondh T, Tam JS, Rappaport R, Eldridge JH, Gruber WC.

Clin Vaccine Immunol. 2008 Jul;15(7):1042-53. doi: 10.1128/CVI.00397-07. Epub 2008 Apr 30.

11.

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.

Tam JS, Capeding MR, Lum LC, Chotpitayasunondh T, Jiang Z, Huang LM, Lee BW, Qian Y, Samakoses R, Lolekha S, Rajamohanan KP, Narayanan SN, Kirubakaran C, Rappaport R, Razmpour A, Gruber WC, Forrest BD; Pan-Asian CAIV-T Pediatric Efficacy Trial Network.

Pediatr Infect Dis J. 2007 Jul;26(7):619-28.

PMID:
17596805
12.

Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.

Fenili D, Brown M, Rappaport R, McLaurin J.

J Mol Med (Berl). 2007 Jun;85(6):603-11. Epub 2007 Feb 6.

PMID:
17279347
13.

Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.

Yang DP, Zielinska E, Quiroz J, Madore D, Rappaport R.

Biologicals. 2007 Jun;35(3):183-7. Epub 2007 Jan 22.

PMID:
17241789
14.

Losing your rights: complications of misdiagnosis.

Rappaport RG.

J Am Acad Psychiatry Law. 2006;34(4):436-8. No abstract available.

PMID:
17185470
15.

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.

Vesikari T, Fleming DM, Aristegui JF, Vertruyen A, Ashkenazi S, Rappaport R, Skinner J, Saville MK, Gruber WC, Forrest BD; CAIV-T Pediatric Day Care Clinical Trial Network.

Pediatrics. 2006 Dec;118(6):2298-312.

PMID:
17142512
16.

Semiquantitative one-step RT-PCR for simultaneous identification of human influenza and respiratory syncytial viruses.

Chi XS, Li F, Tam JS, Rappaport R, Cheng SM.

J Virol Methods. 2007 Jan;139(1):90-2. Epub 2006 Oct 9.

PMID:
17030067
17.

Genetic and phylogenetic analysis of multi-continent human influenza A(H1N2) reassortant viruses isolated in 2001 through 2003.

Chen MJ, La T, Zhao P, Tam JS, Rappaport R, Cheng SM.

Virus Res. 2006 Dec;122(1-2):200-5. Epub 2006 Sep 12.

PMID:
16971014
19.

A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine.

Vesikari T, Karvonen A, Korhonen T, Edelman K, Vainionpää R, Salmi A, Saville MK, Cho I, Razmpour A, Rappaport R, O'Neill R, Georgiu A, Gruber W, Mendelman PM, Forrest B; CAIV-T Transmission Study Group.

Pediatr Infect Dis J. 2006 Jul;25(7):590-5.

PMID:
16804427
20.

Use of PCR to demonstrate presence of adenovirus species B, C, or F as well as coinfection with two adenovirus species in children with flu-like symptoms.

Echavarria M, Maldonado D, Elbert G, Videla C, Rappaport R, Carballal G.

J Clin Microbiol. 2006 Feb;44(2):625-7.

21.

Molecular evolution of human influenza A/H3N2 virus in Asia and Europe from 2001 to 2003.

Chi XS, Bolar TV, Zhao P, Tam JS, Rappaport R, Cheng SM.

J Clin Microbiol. 2005 Dec;43(12):6130-2.

22.

Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation.

Lambermon MH, Rappaport RV, McLaurin J.

J Neurochem. 2005 Dec;95(6):1667-76. Epub 2005 Nov 21.

23.
24.

Development of a real-time RT-PCR assay for detection and quantitation of parainfluenza virus 3.

Hu A, Colella M, Zhao P, Li F, Tam JS, Rappaport R, Cheng SM.

J Virol Methods. 2005 Dec;130(1-2):145-8. Epub 2005 Aug 1.

PMID:
16076498
25.

CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development.

Pinto G, Abadie V, Mesnage R, Blustajn J, Cabrol S, Amiel J, Hertz-Pannier L, Bertrand AM, Lyonnet S, Rappaport R, Netchine I.

J Clin Endocrinol Metab. 2005 Oct;90(10):5621-6. Epub 2005 Jul 19.

PMID:
16030162
26.

Detection and characterization of new influenza B virus variants in 2002.

Chi XS, Hu A, Bolar TV, Al-Rimawi W, Zhao P, Tam JS, Rappaport R, Cheng SM.

J Clin Microbiol. 2005 May;43(5):2345-9.

27.

Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain.

Mendelman PM, Rappaport R, Cho I, Block S, Gruber W, August M, Dawson D, Cordova J, Kemble G, Mahmood K, Palladino G, Lee MS, Razmpour A, Stoddard J, Forrest BD.

Pediatr Infect Dis J. 2004 Nov;23(11):1053-5.

PMID:
15545863
28.

Detection of influenza B in clinical specimens: comparison of high throughput RT-PCR and culture confirmation.

Cheng SM, Vainionpaa R, Zhao P, Li F, Hu A, Forrest B, Rappaport R.

Virus Res. 2004 Jul;103(1-2):85-90.

PMID:
15163494
30.

Cocirculation and evolution of two lineages of influenza B viruses in europe and Israel in the 2001-2002 season.

Chi XS, Bolar TV, Zhao P, Rappaport R, Cheng SM.

J Clin Microbiol. 2003 Dec;41(12):5770-3.

31.

[Biological and genetic tests for sexual development disorders].

Fellous M, Morel Y, Rappaport R.

Arch Pediatr. 2003 May;10 Suppl 1:85s-89s. French. No abstract available.

PMID:
14509753
32.

Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR.

Hu A, Colella M, Tam JS, Rappaport R, Cheng SM.

J Clin Microbiol. 2003 Jan;41(1):149-54.

33.

Effects of growth hormone on growth factors after renal transplantation.

Clot JP, Crosnier H, Guest G, Saucet C, Souberbielle JC, Andre JL, Broyer M, Rappaport R, Benelli C.

Pediatr Nephrol. 2001 May;16(5):397-403.

PMID:
11405112
34.

Looking at monopolization in renal care: the Gambro anti-trust case.

Rappaport RJ, Pristave R.

Nephrol News Issues. 1999 Nov;13(11):16-7. No abstract available.

PMID:
10865619
35.

Growth response to rhIGF-I 80 microg/kg twice daily in children with growth hormone insensitivity syndrome: relationship to severity of clinical phenotype.

Azcona C, Preece MA, Rose SJ, Fraser N, Rappaport R, Ranke MB, Savage MO.

Clin Endocrinol (Oxf). 1999 Dec;51(6):787-92.

PMID:
10619985
37.

Follow up of precocious pseudopuberty associated with isolated ovarian follicular cysts.

Rodriguez-Macias KA, Thibaud E, Houang M, Duflos C, Beldjord C, Rappaport R.

Arch Dis Child. 1999 Jul;81(1):53-6.

39.

Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology.

Guest G, Bérard E, Crosnier H, Chevallier T, Rappaport R, Broyer M.

Pediatr Nephrol. 1998 Aug;12(6):437-46.

PMID:
9745864
40.

Swyer syndrome and 46,XY partial gonadal dysgenesis associated with 9p deletions in the absence of monosomy-9p syndrome.

Veitia RA, Nunes M, Quintana-Murci L, Rappaport R, Thibaud E, Jaubert F, Fellous M, McElreavey K, Gonçalves J, Silva M, Rodrigues JC, Caspurro M, Boieiro F, Marques R, Lavinha J.

Am J Hum Genet. 1998 Sep;63(3):901-5. No abstract available.

41.

Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation.

Fjellestad-Paulsen A, Czernichow P, Brauner R, Bost M, Colle M, Lebouc JY, Lecornu M, Leheup B, Limal JM, Raux MC, Toublanc JE, Rappaport R.

Acta Paediatr. 1998 May;87(5):511-7.

PMID:
9641731
42.

Shedding of rotavirus after administration of the tetravalent rhesus rotavirus vaccine.

Ward RL, Dinsmore AM, Goldberg G, Sander DS, Rappaport RS, Zito ET.

Pediatr Infect Dis J. 1998 May;17(5):386-90.

PMID:
9613651
43.

Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group.

Ward RL, Knowlton DR, Zito ET, Davidson BL, Rappaport R, Mack ME.

J Infect Dis. 1997 Sep;176(3):570-7.

PMID:
9291301
44.

Attenuation of a human rotavirus vaccine candidate did not correlate with mutations in the NSP4 protein gene.

Ward RL, Mason BB, Bernstein DI, Sander DS, Smith VE, Zandle GA, Rappaport RS.

J Virol. 1997 Aug;71(8):6267-70.

45.

Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor.

Misrahi M, Meduri G, Pissard S, Bouvattier C, Beau I, Loosfelt H, Jolivet A, Rappaport R, Milgrom E, Bougneres P.

J Clin Endocrinol Metab. 1997 Jul;82(7):2159-65.

PMID:
9215288
46.

Cleavage furrow establishment by the moving mitotic apparatus.

Rappaport R.

Dev Growth Differ. 1997 Apr;39(2):221-6.

PMID:
9108335
47.

A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.

Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, Limal JM, Rochiccioli P, Soskin S.

J Clin Endocrinol Metab. 1997 Feb;82(2):452-6.

PMID:
9024235
48.

Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer.

Athma P, Rappaport R, Swift M.

Cancer Genet Cytogenet. 1996 Dec;92(2):130-4.

PMID:
8976369
49.
50.

Three years of GH treatment in Turner's syndrome: complex effect of GH dosage on growth parameters. French Pediatric Clinics and Sanofi-Winthrop.

Bertrand AM, Chaussain JL, Job B, Mariani R, Ponte C, Rappaport R, Rochiccioll P, Chatelain P.

Clin Endocrinol (Oxf). 1996 Jun;44(6):665-71.

PMID:
8759178

Supplemental Content

Loading ...
Support Center